Evidence map›Paper›PMID 34361994›Full record

ArticleJournal of clinical medicine2021

Consequences of the COVID-19 Outbreak Lockdown on Non-Viral Infectious Agents as Reported by a Laboratory-Based Surveillance System at the IHU Méditerranée Infection, Marseille, France.

Lanceï Kaba, Audrey Giraud-Gatineau, Marie-Thérèse Jimeno, Jean-Marc Rolain, Philippe Colson, Didier Raoult, Hervé Chaudet

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Impacts of COVID-19 pandemic on culture-proven sepsis in neonates.Frontiers in cellular and infection microbiology · 2024
    Article
  4. Impact of the COVID-19 pandemic on prevalence of highly resistant microorganisms in hospitalised patients in the Netherlands, March 2020 to August 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023
    Article
  5. COVID-19 Is a Confounder of IncreasedPathogens (Basel, Switzerland) · 2023
    Article
  6. Control of common viral epidemics but not of SARS-CoV-2 through the application of hygiene and distancing measures.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Lanceï KabaIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.ORCID 0000-0002-3699-783X
Audrey Giraud-GatineauIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Marie-Thérèse JimenoAssistance Publique-Hôpitaux de Marseille (AP-HM), 13005 Marseille, France.
Jean-Marc RolainIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Philippe ColsonIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.ORCID 0000-0001-6285-0308
Didier RaoultIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Hervé ChaudetIHU Méditerranée Infection, 19-21 Boulevard Jean Moulin, 13005 Marseille, France.
Aix-Marseille Université · FRAssistance Publique Hôpitaux de Marseille · FR

Funding

Agence Nationale de la Recherche Méditerranée-Infection 10-IAHU-03European Regional Development Fund FEDER PRIMMI
6 · The paper itself

Abstract

The objective of this paper is to describe the surveillance system MIDaS and to show how this system has been used for evaluating the consequences of the French COVID-19 lockdown on the bacterial mix of AP-HM and the antibiotic resistance. MIDas is a kind of surveillance activity hub, allowing the automatic construction of surveillance control boards. We investigated the diversity and resistance of bacterial agents from respiratory, blood, and urine samples during the lockdown period (from week 12 to 35 of 2020), using the same period of years from 2017 to 2019 as control. Taking into account the drop in patient recruitment, several species have exhibited significant changes in their relative abundance (either increasing or decreasing) with changes up to 9%. The changes were more important for respiratory and urine samples than for blood samples. The relative abundance in respiratory samples for the whole studied period was higher during the lockdown. A significant increase in the percentage of wild phenotypes during the lockdown was observed for several species. The use of the MIDaS syndromic collection and surveillance system made it possible to efficiently detect, analyze, and follow changes of the microbiological population as during the lockdown period.

Indexed as

clinical microbiology laboratoryCOVID-19diversityepidemiologylockdownsyndromic surveillancewild

Identifiers

PMID34361994
PMCPMC8348674
OpenAlexW3184752764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.